Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Karuna Therapeutics Inc
(NQ:
KRTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Karuna Therapeutics Inc
< Previous
1
2
3
4
5
Next >
Premarket Moves: Nike Dips 11%, Karuna Therapeutics Soars 48%
December 22, 2023
Friday has seen several stocks make notable moves ahead of the market opening, with Nike (NKE) and Karuna Therapeutics (KRTX) capturing the most attention.
Via
Talk Markets
Karuna Stock Soars On Bristol Myers' $14 Billion Takeover
December 22, 2023
Karuna is working on treatments for schizophrenia and Alzheimer's disease psychosis.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 22, 2023
Via
Benzinga
Where Karuna Therapeutics Stands With Analysts
December 12, 2023
Via
Benzinga
The Latest Analyst Ratings for Karuna Therapeutics
November 20, 2023
Via
Benzinga
Karuna Therapeutics Says Its Antipsychotic Candidate Shows Favorable Cardiovascular Safety Profile In Schizophrenia Patients
November 17, 2023
Karuna Therapeutics Inc (NASDAQ: KRTX) released results from its Phase 1b open-label, eight-week inpatient trial evaluating the effect of KarXT (xanomeline-trospium) on 24-hour ambulatory blood...
Via
Benzinga
Analyst Expectations for Karuna Therapeutics's Future
November 03, 2023
Via
Benzinga
What 9 Analyst Ratings Have To Say About Karuna Therapeutics
September 28, 2023
Via
Benzinga
Analyst Expectations for Karuna Therapeutics's Future
September 08, 2023
Via
Benzinga
Karuna Takes A Big Step In Schizophrenia Treatment. Shares Jump Higher.
September 28, 2023
Karuna Therapeutics says it could have the first new mechanism for schizophrenia treatment in decades.
Via
Investor's Business Daily
10 Analysts Have This to Say About Karuna Therapeutics
August 22, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2023
August 22, 2023
Via
Benzinga
The Latest Analyst Ratings for Karuna Therapeutics
August 04, 2023
Via
Benzinga
The Latest Analyst Ratings for Karuna Therapeutics
July 13, 2023
Via
Benzinga
Where Karuna Therapeutics Stands With Analysts
June 01, 2023
Via
Benzinga
The Latest Analyst Ratings for Karuna Therapeutics
May 16, 2023
Via
Benzinga
Karuna Therapeutics's Return On Capital Employed Overview
May 12, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2023
July 20, 2023
Via
Benzinga
What Are Latest Investor Thoughts On Karuna Therapeutics? Analyst Sees Buying Opportunity
July 14, 2023
William Blair notes increasing investor inbounds on Karuna Therapeutics Inc (NASDAQ: KRTX) given the recent pullback, as the stock is down 13% off June 2023 highs and 25% off 52-week highs
Via
Benzinga
3 Biotech Buyout Targets to Watch
April 29, 2023
The trio all have late-stage therapies with blockbuster potential.
Via
The Motley Fool
Why Shares of Karuna Therapeutics Were Up Wednesday
March 22, 2023
The clinical-stage biotech announced positive trial results for its lead therapy.
Via
The Motley Fool
Analyst Expectations for Karuna Therapeutics's Future
March 21, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
July 06, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
June 29, 2023
Via
Benzinga
Royalty Pharma Reaffirms FY23 Guidance Post Mixed Q1 Performance
May 09, 2023
Via
Benzinga
PureTech Health FY22 Revenue Declines 10.2% YoY, Here Are The Details
April 28, 2023
PureTech Health plc (NASDAQ: PRTC) (LSE:PRTC) released its results for the year ended December 31, 2022, revealing revenue of $15.6 million, a decrease of 10.2% compared to $17.4 million in 2021....
Via
Benzinga
Travelzoo, Semler Scientific, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday
March 22, 2023
U.S. stocks traded mostly higher, with the Dow Jones gaining around 20 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 22, 2023
Gainers Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) shares jumped 69.6% to $15.01 after dropping 24% on Tuesday.
Via
Benzinga
Why Citi Trends Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 21, 2023
Gainers U.S. Xpress Enterprises, Inc. (NYSE: USX) shares surged 298% to $5.97 after Knight-Swift Transportation agreed to acquire the company for $6.15 per share.
Via
Benzinga
ENPH Stock Price Prediction: Can Enphase Energy Really Hit $225?
March 20, 2023
Enphase Energy (ENPH) stock is continuing to rise higher on Monday after an upgrade on Friday gave the company's shares a boost.
Via
InvestorPlace
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.